CONTRAST MEDIA INJECTORS MARKET ANALYSIS

Contrast Media Injectors Market, By Product Type (CT Injectors, MRI Injectors, Cardio Injectors), By End User (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027

Published In : Dec 2019
Code : CMI3157
Pages :85
Formats :
Excel and PDF
Industry : Medical Devices

Contrast Media Injectors MarketSize and Trends

The global contrast media injectors market is estimated to account for US$ 2,000.7 Mn in terms of value and 49,381 units in terms of volume by the end of 2027.

CT Injectors segment in the global contrast media injectors market was valued at US$ 514.4 Mn in 2018 and is expected to reach US$ 864.6 by 2027 at a CAGR of 6.0% during the forecast period.

Market Trends/Key Takeaways

The global contrast media injectors market is witnessing increasing adoption of syringeless power injectors, owing to their advantages such as reduced contrast media wastage and higher efficiency compared to dual-syringe injectors.

Moreover, key players in the market are focused on product approval and launch to expand their product portfolio. For instance, in May 2018, General Electric received the U.S.FDA indication approval for Visipaque (iodixanol) injection for use with coronary CT angiography.